Ciprofloxacin
Cipro, Otiprio (ciprofloxacin) is a small molecule pharmaceutical. Ciprofloxacin was first approved as Cipro on 1990-12-26. It is used to treat anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, and bacteroides infections amongst others in the USA. Ciprodex's patents are valid until 2037-11-12 (FDA).
| Trade Name | Cipro, Otiprio |
|---|---|
| Common Name | Ciprofloxacin |
| Indication | anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, bacteroides infections, campylobacter infections, cystitis, diarrhea, dysentery, escherichia coli infections, fever, gonorrhea, haemophilus infections, infectious arthritis, intraabdominal infections, klebsiella infections, neutropenia, osteomyelitis, otitis externa, prostatitis, proteus infections, protozoan infections, pseudomonas infections, pyelonephritis, sinusitis, staphylococcal infections, typhoid fever, urinary tract infections |
| Drug Class | Antibacterials (quinolone derivatives) |
